Computational Studies and Molecular Dynamic Simulation to Design Lead Compounds for Hepatitis B Virus
Alfan Danny Arbianto1★, Firdayani f1, Susi Kusumaningrum1, Raodatul Jannah1, Puspa Dewi N Lotulung2, Muhammad Hanafi2★ Corresponding author
- 1Badan Pengkajiandan Penerapan Teknologi, JL. MH. Thamrin 8, Jakarta 10340, INDONESIA.
- 2Puslit Kimia LIPI, Kawasan Puspiptek, Serpong, INDONESIA.
CORRESPONDENCE
Alfan Danny Arbianto
Badan Pengkajiandan Penerapan Teknologi, JL. MH. Thamrin 8, Jakarta 10340, INDONESIA.
Received: 20-02-2018; Revised: 04-03-2018; Accepted: 13-05-2018.
Volume 10, Issue 2S · pp. s148–s152 · PUBLISHED · DOI: 10.5530/jyp.2018.2s.31
ABSTRACT
Objective/Background: A novel approach to develop anti-Hepatitis B Virus (HBV) by computational studies is proposed. Methodology: It used active compounds as the standard ligand. There are six parameters such as docking score, molecular weight, log P, Polarizability, Polar Surface (2D) and Molecular Surface (3D) that analyzed by software. Result and Discussion: The result of virtual screening can be used as a reference to calculate IC50 prediction of quinine and Gallic acid derivative compounds. Optimization of compounds structure geometry was using software Marvin Sketch 6.0.1. Meanwhile, virtual docking process to HBV capsid Y132A mutant (PDB ID: 5E0I) was using Autodock4, Auto dock Vina, and Plant. Result: The lowest IC50 prediction is gallic acid (64.1 μM) that had hydrogen and polar interaction for 20 ns. Conclusion: These computational studies not only shed light on understanding the IC50 prediction of the replication of the viral core protein inhibition, but also the stability of each interaction that inhibits of the viral core protein replication.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Arbianto, A. D., f, F., Kusumaningrum, S., Jannah, R., Lotulung, P. D. N., & Hanafi, M. (). Computational Studies and Molecular Dynamic Simulation to Design Lead Compounds for Hepatitis B Virus. Journal of Young Pharmacists, 10(2S), s148–s152. https://doi.org/10.5530/jyp.2018.2s.31
